A detailed history of Wolverine Trading, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 45,359 shares of CRMD stock, worth $468,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,359
Previous 54,014 16.02%
Holding current value
$468,558
Previous $233,000 57.08%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.64 - $8.23 $31,504 - $71,230
-8,655 Reduced 16.02%
45,359 $366,000
Q2 2024

Aug 14, 2024

BUY
$4.08 - $6.39 $166,806 - $261,248
40,884 Added 311.38%
54,014 $233,000
Q1 2024

May 15, 2024

SELL
$2.94 - $4.24 $8,734 - $12,597
-2,971 Reduced 18.45%
13,130 $55,000
Q4 2023

Feb 14, 2024

BUY
$3.0 - $4.01 $48,303 - $64,565
16,101 New
16,101 $60,000
Q2 2023

Aug 23, 2023

BUY
$3.94 - $5.8 $46,098 - $67,860
11,700 New
11,700 $46,000
Q4 2022

Feb 14, 2023

SELL
$2.81 - $4.45 $24,660 - $39,053
-8,776 Reduced 36.96%
14,971 $63,000
Q3 2022

Nov 14, 2022

BUY
$2.82 - $7.52 $10,620 - $28,320
3,766 Added 18.85%
23,747 $67,000
Q2 2022

Aug 15, 2022

BUY
$2.73 - $5.61 $15,307 - $31,455
5,607 Added 39.01%
19,981 $72,000
Q1 2022

May 16, 2022

SELL
$3.83 - $6.24 $28,368 - $46,219
-7,407 Reduced 34.01%
14,374 $84,000
Q3 2021

Nov 12, 2021

BUY
$4.46 - $7.11 $28,271 - $45,070
6,339 Added 41.05%
21,781 $101,000
Q2 2021

Aug 06, 2021

SELL
$6.05 - $10.09 $23,238 - $38,755
-3,841 Reduced 19.92%
15,442 $110,000
Q1 2021

May 14, 2021

BUY
$6.84 - $17.58 $17,989 - $46,235
2,630 Added 15.79%
19,283 $173,000
Q4 2020

Feb 12, 2021

SELL
$5.0 - $9.15 $51,780 - $94,757
-10,356 Reduced 38.34%
16,653 $123,000
Q2 2020

Aug 13, 2020

BUY
$3.08 - $6.56 $21,538 - $45,874
6,993 Added 34.94%
27,009 $167,000
Q1 2020

May 11, 2020

BUY
$2.35 - $7.08 $16,064 - $48,398
6,836 Added 51.87%
20,016 $71,000
Q4 2019

Feb 12, 2020

BUY
$4.96 - $7.75 $65,372 - $102,145
13,180 New
13,180 $90,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $426M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.